Cargando…
Nebulized fentanyl for respiratory symptoms in patients with COVID-19 (ventanyl trial)
Patients with coronavirus disease (COVID-19) commonly experience distressing and challenging respiratory symptoms. Interventions such as oxygen therapy, oral opiates, and traditional nebulizers like ipratropium bromide and salbutamol are variable in their efficacy, and therapy responses in patients...
Autores principales: | Shaikh, Nissar, Khatib, Mohamad Y., Wraidat, Mohammad A. Al, Mohamed, Ahmed S., Al-Assaf, Anood A., Tharayil, Abdul Gafoor M., Abujaber, Ahmad A., Nashwan, Abdulqadir J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797561/ https://www.ncbi.nlm.nih.gov/pubmed/35089202 http://dx.doi.org/10.1097/MD.0000000000028637 |
Ejemplares similares
-
Comparison of the clinical outcomes of non-invasive ventilation by helmet vs facemask in patients with acute respiratory distress syndrome
por: Khatib, Mohamad Y., et al.
Publicado: (2021) -
Rhabdomyolysis in Critically Ill Patients With COVID-19: A Retrospective Study
por: Nashwan, Abdulqadir J, et al.
Publicado: (2023) -
Nebulized versus invasively delivered surfactant therapy for neonatal respiratory distress syndrome: A systematic review and meta-analysis
por: Rong, Hui, et al.
Publicado: (2020) -
Ocular manifestations of COVID-19: facts and figures from a tertiary care center
por: Shaikh, Nissar, et al.
Publicado: (2022) -
Laparoscopic Major Vascular Injuries Report of Two Cases and Review
por: Shaikh, Nissar, et al.
Publicado: (2023)